Background To evaluate a wide range of optical coherence tomography (OCT) parameters for possible application as a screening tool for cognitively healthy individuals at risk of Alzheimer’s disease (AD), assessing the potential relationship with established cerebrospinal fluid (CSF) core AD biomarkers and magnetic resonance imaging (MRI). Methods We studied 99 participants from the Valdecilla Study for Memory and Brain Aging. This is a prospective cohort for multimodal biomarker discovery and validation that includes participants older than 55 years without dementia. Participants received a comprehensive neuropsychological battery and underwent structural 3-T brain MRI, lumbar puncture for CSF biomarkers (phosphorylated-181-Tau (pTau), total...
To evaluate the ability of frequency domain optical coherence tomography (fd-OCT) to estimate retina...
0Background/aim: To evaluate, in vivo, the optical coherence tomography (OCT) of the retinal nerve f...
Alzheimer’s disease (AD) is a neurodegenerative disorder, which starts as mild cognitive impairment ...
The use of optical coherence tomography (OCT) has been suggested as a potential biomarker for Alzhei...
The use of optical coherence tomography (OCT) has been suggested as a potential biomarker for Alzhei...
BACKGROUND: Alzheimers disease (AD) pathology precedes symptoms and its detection can identify at-ri...
Several papers support the existence of a possible link between reduced retinal thickness and Alzhei...
Building on previous studies that report thinning of the macula in Alzheimer's disease (AD) and mild...
PURPOSE:To evaluate differences between the retinal nerve fiber layer (RNFL) thickness and RNFL + ga...
Neurodegeneration in dementia is mainly evaluated by assessing cerebral atrophy, while retinal neuro...
Purpose: Several studies found reduced retinal thickness on optical coherence tomography (OCT) in Al...
BackgroundAlzheimer's disease (AD) pathology precedes symptoms and its detection can identify at-ris...
Background and purpose: A reduction of retinal thickness and an alteration of retinal perfusion have...
Background and purpose: A reduction of retinal thickness and an alteration of retinal perfusion have...
INTRODUCTION: In patients with Alzheimer's disease (AD) and mild cognitive impairment, structural ch...
To evaluate the ability of frequency domain optical coherence tomography (fd-OCT) to estimate retina...
0Background/aim: To evaluate, in vivo, the optical coherence tomography (OCT) of the retinal nerve f...
Alzheimer’s disease (AD) is a neurodegenerative disorder, which starts as mild cognitive impairment ...
The use of optical coherence tomography (OCT) has been suggested as a potential biomarker for Alzhei...
The use of optical coherence tomography (OCT) has been suggested as a potential biomarker for Alzhei...
BACKGROUND: Alzheimers disease (AD) pathology precedes symptoms and its detection can identify at-ri...
Several papers support the existence of a possible link between reduced retinal thickness and Alzhei...
Building on previous studies that report thinning of the macula in Alzheimer's disease (AD) and mild...
PURPOSE:To evaluate differences between the retinal nerve fiber layer (RNFL) thickness and RNFL + ga...
Neurodegeneration in dementia is mainly evaluated by assessing cerebral atrophy, while retinal neuro...
Purpose: Several studies found reduced retinal thickness on optical coherence tomography (OCT) in Al...
BackgroundAlzheimer's disease (AD) pathology precedes symptoms and its detection can identify at-ris...
Background and purpose: A reduction of retinal thickness and an alteration of retinal perfusion have...
Background and purpose: A reduction of retinal thickness and an alteration of retinal perfusion have...
INTRODUCTION: In patients with Alzheimer's disease (AD) and mild cognitive impairment, structural ch...
To evaluate the ability of frequency domain optical coherence tomography (fd-OCT) to estimate retina...
0Background/aim: To evaluate, in vivo, the optical coherence tomography (OCT) of the retinal nerve f...
Alzheimer’s disease (AD) is a neurodegenerative disorder, which starts as mild cognitive impairment ...